Trial Profile
Phase 2 Trial of V-5 Immunitor (V5) in Patients with Chronic Hepatitis C Co-infected with HIV and Mycobacterium tuberculosis
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 07 Jan 2011
Price :
$35
*
At a glance
- Drugs Hepcortespenlisimut-L (Primary) ; Ethambutol; Isoniazid; Pyrazinamide; Rifampicin; Streptomycin
- Indications Hepatitis C
- Focus Therapeutic Use
- Sponsors Immunitor